Basic Course: Regenerative Medicine + Peptide Therapeutics

This enduring educational program provides healthcare professionals with a comprehensive, evidence-based foundation in regenerative medicine and peptide therapeutics. The program examines the biological mechanisms of tissue repair, the major classes of regenerative biologics, and their current and emerging applications in orthopedic, neurologic, metabolic, and other clinical conditions.

Participants will explore patient evaluation and selection, treatment planning, delivery methods, pharmacology, safety monitoring, product quality, and the integration of rehabilitation and longitudinal outcome assessment. The program also reviews MUSE cells, regenerative protein arrays, secretome-based approaches, and clinically relevant peptide therapies, while clearly distinguishing established applications from investigational or unsupported claims.

Throughout the program, emphasis is placed on critical appraisal of the scientific evidence, regulatory and ethical responsibilities, informed consent, accurate clinical communication, and the development of safe, reproducible, and defensible clinical workflows.

Target Audience

This activity is designed for an audience of physicians and other qualified healthcare professionals involved in regenerative medicine, peptide therapeutics, neurology, psychiatry, addiction medicine, internal medicine, cardiology, pulmonology, hepatology, rheumatology, fertility medicine, dermatology, pain medicine, physical medicine and rehabilitation, and longevity medicine. The course is also appropriate for nurse practitioners, physician assistants, and other licensed clinicians seeking advanced, evidence-informed education in the evaluation and management of complex cases.

Learning Objectives

Upon completion of this activity, participants should be able to:

Describe the biological mechanisms underlying regenerative medicine and peptide therapeutics, including trophic signaling, immunomodulation, structural repair, receptor pharmacology, and tissue-specific regenerative processes.
Differentiate major regenerative and peptide-based therapeutic approaches according to their biological source, mechanism of action, clinical evidence, regulatory status, manufacturing quality, and potential risks.
Evaluate the available evidence for regenerative interventions and peptide therapies used in orthopedic, neurologic, metabolic, tissue-repair, immune, reproductive, and longevity-related clinical applications.
Apply structured patient-evaluation, phenotyping, and selection criteria to determine whether a regenerative or peptide-based intervention is clinically appropriate.
Develop evidence-informed treatment and monitoring plans that incorporate appropriate delivery methods, image guidance when indicated, rehabilitation, validated outcome measures, safety surveillance, and longitudinal follow-up.
Assess the plausibility and clinical validity of therapeutic claims by examining pharmacokinetics, pharmacodynamics, route of administration, product identity, purity, potency, and the quality of supporting evidence. Implement ethical, regulatory, and risk-management principles—including informed consent, accurate marketing, documentation, escalation pathways, and evidence-aligned communication—within a responsible regenerative medicine or peptide therapeutics practice.

Commercial Support
There is no commercial support for this activity.

Course summary

Available credit:

8.00 AANP Contact Hours
Nurse Practitioners
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and Institute for Regenerative Medicine and Neuroscience. AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 8.00 contact hour(s) (which includes 8.00 hour(s) of pharmacology).
- 8.00 AANP Pharmacology Contact Hours
8.00 AAPA Category 1 CME
Physician Associates
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 8.00 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
8.00 AMA PRA Category 1 Credit™
Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this Enduring Material for a maximum of 8.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
8.00 ANCC Contact Hours
Nurses
Credit being awarded: 8.00 ANCC contact hours
8.00 AMA PRA Category 1 Credit™ Non-MD
Non-Physicians Seeking AMA Credit
AKH Inc., Advancing Knowledge in Healthcare designates this Enduring Material for a maximum of 8.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Course opens:

08/24/2026

Course expires:

12/31/2027

Cost:

$0.00

Rating:

All of the relevant financial relationships listed for these individuals have been mitigated.

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with "Opt Out" in the subject line.

Committee Member, Planner, Staff(s)